Education
About Us
Working with TipRanks
Follow Us
EnBio Holdings, Inc. (JP:6092)
:6092
6092 Stock Chart & Stats
¥598.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥598.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥500.00 - ¥746.00
Previous CloseN/A
Volume5.80K
Average Volume (3M)25.91K
Market Cap
¥5.95B
Enterprise Value¥12.50B
Total Cash (Recent Filing)¥3.19B
Total Debt (Recent Filing)¥10.28B
Price to Earnings (P/E)―
Beta0.61
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.54%
Share Statistics
EPS (TTM)-75.25
Shares Outstanding8,175,200
10 Day Avg. Volume21,320
30 Day Avg. Volume25,910
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)0.53
Price to Sales (P/S)0.45
P/FCF Ratio-3.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent revenue growth of ~11.4% across the latest fiscal year indicates durable demand and successful commercial execution. Over a 2-6 month horizon this supports market position, underwriting of ongoing investments, and a stronger base for margin expansion or reinvestment.
Operational MarginsHealthy EBIT and EBITDA margins (7.95% and 12.58%) reflect operational efficiency and pricing power in core services. Sustained mid-teens EBITDA-like margins provide durable cash-earnings capacity to fund growth, service debt and absorb industry cycles over months to quarters.
Balanced Capital StructureA debt-to-equity near 1.10 and a ~43% equity ratio indicate a conservative, balanced leverage profile. This structure provides financial flexibility to fund capex or M&A, helps preserve liquidity in downturns, and reduces refinancing risk over the medium term.
Bears Say
Weak Cash ConversionNegative free cash flow and an operating-cash-to-net-income ratio of 0.05 show poor cash conversion and high capex demands. Persistently weak cash generation can force external financing, constrain reinvestment, and limit ability to sustainably fund dividends or deleveraging.
Falling ProfitabilityA decline in net income alongside a modest 4.24% net margin signals pressure on bottom-line profitability. If structural, this reduces retained earnings and weakens the company's ability to build reserves or invest in growth initiatives, affecting long-term resilience.
Low Return On EquityROE of ~4.95% indicates limited efficiency in converting equity into profits. Over time, low ROE can deter capital allocation, signal weak competitive returns versus peers, and constrain shareholder value creation absent operational or strategic improvement.
EnBio Holdings, Inc. News
6092 FAQ
What was EnBio Holdings, Inc.’s price range in the past 12 months?
EnBio Holdings, Inc. lowest stock price was ¥500.00 and its highest was ¥746.00 in the past 12 months.
What is EnBio Holdings, Inc.’s market cap?
EnBio Holdings, Inc.’s market cap is ¥5.95B.
When is EnBio Holdings, Inc.’s upcoming earnings report date?
EnBio Holdings, Inc.’s upcoming earnings report date is May 20, 2026 which is in 70 days.
How were EnBio Holdings, Inc.’s earnings last quarter?
EnBio Holdings, Inc. released its earnings results on Feb 13, 2026. The company reported -¥75.25 earnings per share for the quarter, missing the consensus estimate of N/A by -¥75.25.
Is EnBio Holdings, Inc. overvalued?
According to Wall Street analysts EnBio Holdings, Inc.’s price is currently Overvalued.
Does EnBio Holdings, Inc. pay dividends?
EnBio Holdings, Inc. pays a Annually dividend of ¥9 which represents an annual dividend yield of 1.54%. See more information on EnBio Holdings, Inc. dividends here
What is EnBio Holdings, Inc.’s EPS estimate?
EnBio Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EnBio Holdings, Inc. have?
EnBio Holdings, Inc. has 8,175,200 shares outstanding.
What happened to EnBio Holdings, Inc.’s price movement after its last earnings report?
EnBio Holdings, Inc. reported an EPS of -¥75.25 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.165%.
Which hedge fund is a major shareholder of EnBio Holdings, Inc.?
Currently, no hedge funds are holding shares in JP:6092
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
EnBio Holdings, Inc.
EnBio Holdings Co., Ltd. engages in soil and groundwater contamination, and renewable energy businesses in Japan. It imports and sells equipment, materials, and cleaning agents; and purchases, sells, and leases contaminated land. The company is also involved in solar power; biomass power generation; renewable energy power generation; water resource development; and ethical consumption promotion businesses. EnBio Holdings Co., Ltd. was incorporated in 1999 and is headquartered in Tokyo, Japan.
Technical Analysis
Paraca Inc.
―
SHIKIGAKU Co., Ltd.
―
Nakabayashi Co., Ltd.
―
PHYZ Holdings, Inc.
―
Biken Techno Corporation
―